1.
Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem.
Hoque, R, Chesson, AL
Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. 2009;(5):471-6
Abstract
Zolpidem is a hypnotic which acts at the GABAA receptor and is indicated for short-term insomnia. Sleep related disorders including somnambulism, sleep related eating and sleep-driving have been reported with zolpidem. A 51-year-old insomniac who used zolpidem 10 mg nightly starting at 44 years of age is described. A few weeks after starting zolpidem she began walking, eating, and had one episode of driving while asleep. Episodes of sleep related eating, sleepwalking, and sleeptalking occurred 3 nights per week, 1 to 2 h after sleep onset. After her evaluation, the patient's zolpidem was gradually discontinued, and all sleep related activities immediately ceased. An 18F-FDG-PET was obtained 2 months after discontinuation of zolpidem. The following day, FDG was administered 1 h after oral administration of 10 mg zolpidem, and then a second PET was performed. We report the results and a review of the literature regarding other unintended effects seen with zolpidem use.
2.
Integrated medical-psychiatric treatment of the "crisis phase" in severe protein-energy malnutrition secondary to major eating disorders.
Alfano, V, Bellini, O, De Filippo, E, Alfonsi, L, Pasanisi, F, Contaldo, F
Eating and weight disorders : EWD. 2004;(2):158-62
Abstract
C.A., a 23-year old male was admitted in the clinical nutrition medical ward for severe, complicated protein-energy malnutrition (PEM) [body mass index (BMI) 11.08 kg/m2; body weight kg 35.81 due to major eating disorders. C.A.'s personality was narcissistic, with a rigid psychic structure. During hospitalitation (lasted 72 days) two acute episodes (a possibly self-inflicted damage and a persecution feeling) occurred that we consider as part of the "crisis phase", the period in which the patient's restrictive behaviour is no longer able to keep his personality equilibrium stable. The patient was treated by an integrated medical and psychiatric approach, including periods of never forced parenteral nutrition, nutritional and intensive psychoterapeutic interventions. For a short period the patient received also a pharmacological support (aloperidol orally). Treatment was successful and the patient was discharged completely autonomous and followed up on an outpatient basis. After about one year follow-up he is still in good clinical condition and in sufficient psychological equilibrium.
3.
[Definition and classification of eating disorders].
Nakano, K, Nakajima, H
Nihon rinsho. Japanese journal of clinical medicine. 2001;(3):528-33
Abstract
This paper describes definition and classification of Eating Disorders which centered on the atypical cases. Eating disorders in DSM-IV were further classified into 3 groups. Three groups were Anorexia Nervosa, Bulimia Nervosa and Eating Disorders Not Otherwise Specified. Binge Eating Disorders frequently transfer to obese patient. This disease entity become independent of Anorexia Nervosa and Bulimia Nervosa. Body weight changing trend evaluated not only cross section but also longitudinal observation. There are some experience cases which Anorexia Nervosa cause by diet therapy of obesity patient. A lot of Eating Disorder patients revealed atypical courses during clinical treatment. The symptom of disturbances in the way in which their body weight and sharp could not easy to confirm routine history taking. One type of eating disorders eat throughout the day with no planned mealtimes.